Alzheimer's Research: Perhaps a Tug of War, But Worth It

Alzheimer's Research: Perhaps a Tug of War, But Worth It

11.28.11 | By Kate Connors

Lately, Jen's been doing a great job of highlighting both the strong need for progress in the battle against Alzheimer's Disease and the hard work that is going into fighting that battle.
A column in the L.A. Times last week, looking at a study in the Journal of Alzheimer's Disease, paints a bold picture about just how tough the challenges are in Alzheimer's research - and how our evolving understanding of the disease can, at times, lead to "one step forward, one step back."
It reminded me of what I heard a few weeks ago while visiting a member company's R&D facility: that we are beginning to believe that Alzheimer's, like cancer, may be a variety of different diseases, with different causes. If so, it will need many different treatments.
It's an intimidating thought - just as the message from this new study is. But if it is true, it may be - again, just as the message from the new study is - another step forward in our understanding of a very little-understood disease.
If I can paraphrase the old saying about the press, perhaps all knowledge is good knowledge if it helps us to move forward.

More On PhRMA — powered by PhRMApedia


Cost in Context